A Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- NHL
Condition: B-cell Non Hodgkin Lymphoma Intervention: Biological: GC022F Sponsors: Hebei Yanda Ludaopei Hospital; Gracell Biotechnology Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials